AARGAU, Switzerland—In keeping with its global expansion strategy, Sumitomo Rubber Industries Ltd. will establish a new production site in Slovenia to manufacture rubber parts for medical applications.
The Japanese company said Aug. 1 it plans to invest about $39.8 million in the facility that will become part of its recently-acquired pharmaceutical packaging business Lonstroff A.G., which is based in Switzerland.
As part of the investment, a new company—Lonstroff Medical Elastomers d.o.o.—will be set up in Slovenia in August. The start of operation of the Slovenian subsidiary is planned in April 2019.
The facility will be built on a 323,000-sq.-ft. site, and will employ 200 once operational.
Lonstroff A.G. produces and sells rubber parts for pharmaceutical primary packaging and rubber parts for medical applications to major pharmaceutical and medical companies. SRI bought the business in January of 2015.
According to SRI, the new plant will triple the company's production capacity of primary packaging and rubber parts for medical applications in Europe.